Evaluation of a Safer Opioid Prescribing Protocol (SOPP) for Patients Being Discharged From a Trauma Service.
Adolescent
Adult
Aged
Aged, 80 and over
Analgesics, Opioid
/ administration & dosage
Benchmarking
Clinical Protocols
/ standards
Female
Humans
Male
Middle Aged
Multiple Trauma
/ nursing
Naloxone
/ administration & dosage
Narcotic Antagonists
/ administration & dosage
Pain
/ drug therapy
Patient Discharge
Patient Safety
Practice Patterns, Physicians'
/ standards
Prospective Studies
Rhode Island
Trauma Centers
Young Adult
Journal
Journal of trauma nursing : the official journal of the Society of Trauma Nurses
ISSN: 1078-7496
Titre abrégé: J Trauma Nurs
Pays: United States
ID NLM: 9512997
Informations de publication
Date de publication:
Historique:
entrez:
5
9
2019
pubmed:
5
9
2019
medline:
24
3
2020
Statut:
ppublish
Résumé
The aims of this study were to evaluate the effects on opioid medication prescribing, patient opioid safety education, and prescribing of naloxone following implementation of a Safer Opioid Prescribing Protocol (SOPP) as part of the electronic health record (EHR) system at a Level I trauma center. This was a prospective observational study of the EHR of trauma patients pre- (n = 191) and post-(n = 316) SOPP implementation between 2014 and 2016. At a comparison Level I trauma site not implementing SOPP, EHRs for the same time period were assessed for any historical trends in opioid and naloxone prescribing. After SOPP implementation, the implementation site increased the use of nonnarcotic pain medication, decreased dispensing high opioid dose (≥100 MME [milligram morphine equivalent]), significantly increased the delivery of opioid safety education to patients, and initiated prescribing naloxone. These changes were not found in the comparison site. Opioid prescribing for acute pain can be effectively reduced in a busy trauma setting with a guideline intervention incorporated into an EHR. Guidelines can increase the use of nonnarcotic medications for the treatment of acute pain and increase naloxone coprescription for patients with a higher risk of overdose.
Identifiants
pubmed: 31483766
doi: 10.1097/JTN.0000000000000435
pii: 00043860-201905000-00002
pmc: PMC6727973
mid: NIHMS1522953
doi:
Substances chimiques
Analgesics, Opioid
0
Narcotic Antagonists
0
Naloxone
36B82AMQ7N
Types de publication
Journal Article
Observational Study
Langues
eng
Pagination
113-120Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Organisme : NCIPC CDC HHS
ID : U01 CE002516
Pays : United States
Références
Am J Public Health. 2004 Mar;94(3):361-6
pubmed: 14998794
Addiction. 2005 Aug;100(8):1101-9
pubmed: 16042640
Addiction. 2006 Sep;101(9):1299-305
pubmed: 16911729
Ann Intern Med. 2010 Jan 19;152(2):85-92
pubmed: 20083827
Clin J Am Soc Nephrol. 2011 Feb;6(2):326-33
pubmed: 21071517
Drug Alcohol Depend. 2011 Jun 1;115(3):221-8
pubmed: 21131140
JAMA. 2011 Apr 6;305(13):1315-21
pubmed: 21467284
Pain Med. 2011 Jun;12 Suppl 2:S26-35
pubmed: 21668754
MMWR Morb Mortal Wkly Rep. 2012 Jan 13;61(1):10-3
pubmed: 22237030
Arch Intern Med. 2012 Mar 12;172(5):425-30
pubmed: 22412106
Pain Physician. 2012 Jul;15(3 Suppl):ES67-92
pubmed: 22786463
Drug Alcohol Depend. 2013 Feb 1;128(1-2):104-10
pubmed: 22974490
J Trauma Acute Care Surg. 2014 Mar;76(3):833-9
pubmed: 24553557
Am J Public Health. 2014 Aug;104(8):e7-9
pubmed: 24922133
J Med Toxicol. 2014 Dec;10(4):431-4
pubmed: 25316516
Med Care. 2015 Aug;53(8):679-85
pubmed: 26172937
Lancet. 2016 Apr 16;387(10028):1644-56
pubmed: 26852264
JAMA. 2016 Apr 19;315(15):1654-7
pubmed: 26978756
MMWR Recomm Rep. 2016 Mar 18;65(1):1-49
pubmed: 26987082
BMJ. 2017 Mar 14;356:j760
pubmed: 28292769
J Pain. 2017 Aug;18(8):956-963
pubmed: 28347798
Drug Alcohol Depend. 2017 Sep 1;178:130-135
pubmed: 28647680
Drug Alcohol Depend. 2017 Sep 1;178:223-230
pubmed: 28666181
Drug Alcohol Depend. 2017 Sep 1;178:501-511
pubmed: 28719884
J Am Acad Orthop Surg. 2019 Jan 1;27(1):32-38
pubmed: 30199478
N Engl J Med. 1988 Jun 30;318(26):1728-33
pubmed: 3374545